S&P 500

5.431,60

-0,04%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Pharmadrug Inc (PK) (LMLLF)
Pharmadrug Inc (PK) (LMLLF) Notícias

LMLLF

Pharmadrug (PK) (LMLLF)

Pharmadrug Inc (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:LMLLF

1

Data	Hora	Fonte	Título	Código	Companhia
23/05/2024	13:34	AllPennyStocks.com	Specialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade Cocaine	USOTC:LMLLF	Pharmadrug Inc (PK)
29/09/2021	11:20	AllPennyStocks.com	Pharma Stock Bid Up For Second Day!	USOTC:LMLLF	Pharmadrug Inc (PK)
20/04/2021	10:41	InvestorsHub NewsWire	PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES	USOTC:LMLLF	Pharmadrug Inc (PK)
16/03/2021	09:10	InvestorsHub NewsWire	PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH	USOTC:LMLLF	Pharmadrug Inc (PK)
25/02/2021	10:13	InvestorsHub NewsWire	PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY	USOTC:LMLLF	Pharmadrug Inc (PK)
11/02/2021	10:18	InvestorsHub NewsWire	PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE	USOTC:LMLLF	Pharmadrug Inc (PK)
08/02/2021	10:00	InvestorsHub NewsWire	PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont	USOTC:LMLLF	Pharmadrug Inc (PK)
04/02/2021	10:58	InvestorsHub NewsWire	PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS	USOTC:LMLLF	Pharmadrug Inc (PK)
02/02/2021	10:48	InvestorsHub NewsWire	PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.	USOTC:LMLLF	Pharmadrug Inc (PK)
12/01/2021	10:40	InvestorsHub NewsWire	PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC	USOTC:LMLLF	Pharmadrug Inc (PK)